196 related articles for article (PubMed ID: 36245227)
1. SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.
Zhu Y; Yang L; Wang J; Li Y; Chen Y
J Gynecol Oncol; 2022 Nov; 33(6):e75. PubMed ID: 36245227
[TBL] [Abstract][Full Text] [Related]
2. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis.
Ou H; Qian Y; Ma L
Aging (Albany NY); 2023 Jul; 15(13):6100-6116. PubMed ID: 37432067
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level.
Li S; Lin L
Environ Toxicol; 2021 Jul; 36(7):1457-1465. PubMed ID: 33783940
[TBL] [Abstract][Full Text] [Related]
4. MCF2L-AS1/miR-874-3p/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance.
Xu M; Zheng J; Wang J; Huang H; Hu G; He H
Heliyon; 2023 Nov; 9(11):e21342. PubMed ID: 37954302
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a.
Chen Q; Wang M; Wu S
Cell Cycle; 2020 May; 19(9):1059-1065. PubMed ID: 32255731
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X
Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling.
Long X; Wen F; Li J; Huang X
Hematol Oncol; 2023 Oct; 41(4):694-703. PubMed ID: 37125488
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis.
Kong W; Li H; Xie L; Cui G; Gu W; Zhang H; Ma W; Zhou Y
BMC Cancer; 2021 Sep; 21(1):1069. PubMed ID: 34592939
[TBL] [Abstract][Full Text] [Related]
10. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.
Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ
Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058
[TBL] [Abstract][Full Text] [Related]
11. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1.
Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX
J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865
[TBL] [Abstract][Full Text] [Related]
13. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
Yao F; Zhao Y; Wang G; Zhao M; Hong X; Ye Z; Dong F; Li W; Deng Q
Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
[TBL] [Abstract][Full Text] [Related]
14. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.
Qin X; Sun L; Wang J
Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
16. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
17. A high level of the long non-coding RNA
She Q; Chen Y; Liu H; Tan J; Li Y
Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells.
Cai J; Wang D; Bai ZG; Yin J; Zhang J; Zhang ZT
PLoS One; 2017; 12(8):e0182433. PubMed ID: 28792527
[TBL] [Abstract][Full Text] [Related]
20. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis.
Zhang Y; Zhang Y; Wang S; Li Q; Cao B; Huang B; Wang T; Guo R; Liu N
Bioengineered; 2021 Dec; 12(1):2299-2310. PubMed ID: 34077295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
